Form 4: Olaplex Director Granted 110K RSUs

Olaplex Holdings, Inc. director Michael James White was granted 110,294 restricted stock units vesting in 2026, increasing his direct beneficial ownership.

Summary

• Director Michael James White of Olaplex Holdings, Inc. was granted 110,294 restricted stock units (RSUs) on August 13, 2025.
• The RSUs were granted under the Issuer's 2021 Equity Incentive Plan at a price of $0.00 per unit.
• Each RSU represents the conditional right to receive one share of Common Stock.
• The RSUs are scheduled to vest in full on the date of Olaplex's 2026 Annual Meeting of Stockholders, contingent on Mr. White's continued service to the Issuer.
• Following this transaction, Mr. White directly beneficially owns 248,693 shares of Common Stock.
• Additionally, Mr. White has indirect beneficial ownership of 499,468,771 shares held by various funds and accounts managed by Advent International, L.P., where he is a Principal, though he disclaims beneficial ownership beyond his pecuniary interest.

Sentiment

Score: 7

Explanation: The grant of RSUs to a director is generally a positive signal, indicating continued commitment and alignment of interests. It's a standard compensation practice, not indicative of immediate financial distress or exceptional performance, hence a neutral-to-positive score.

Positives

• The grant of restricted stock units aligns the director's interests with long-term shareholder value.
• The continued service requirement for vesting indicates a commitment from the director to the company's future.

Negatives

• The RSUs are not immediately exercisable and vest in 2026, meaning no immediate liquidity for the director from this grant.
• The grant price of $0.00 indicates a non-cash compensation, meaning no direct capital infusion from the director for these units at the time of grant.

Risks

• The vesting of the granted RSUs is subject to the reporting person's continued service to the Issuer through the 2026 Annual Meeting of Stockholders, posing a risk of forfeiture if service ceases.

Future Outlook

The vesting of the granted Restricted Stock Units is contingent upon the director's continued service to Olaplex Holdings, Inc. through the 2026 Annual Meeting of Stockholders, indicating an expectation of continued tenure.

Industry Context

This RSU grant is a standard form of equity compensation for directors in publicly traded companies, aiming to align their interests with long-term company performance and shareholder value. It reflects a common practice in the consumer beauty and personal care industry to incentivize leadership.

Comparison to Industry Standards

• The grant of restricted stock units at a $0.00 price is a typical non-cash compensation method for directors, aligning with common practices in the U.S. public market for incentivizing long-term commitment.
• While specific comparable companies or projects are not detailed in this filing, such grants are standard across various sectors, including consumer goods and beauty, for board members.
• The vesting schedule tied to future service is also a standard feature of such equity awards.

Related Party Transactions

• Michael James White's indirect beneficial ownership of 499,468,771 shares is through various funds and accounts managed by Advent International, L.P., where he is a Principal. He disclaims beneficial ownership beyond his pecuniary interest.

Stakeholder Impact

• Shareholders: The director's interests are further aligned with long-term shareholder value through this equity compensation.
• Employees: No direct impact on employees is mentioned in this filing.
• Customers/Suppliers/Creditors: No direct impact on customers, suppliers, or creditors is mentioned in this filing.

Next Steps

• The RSUs are scheduled to vest in full on the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

Key Dates

Recommendation

This Form 4 filing details a routine equity compensation grant to a director, aligning their interests with the company's long-term performance. It does not contain new material information regarding the company's financial health, operational performance, or strategic direction that would warrant a change in investment stance. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide a basis for a 'buy' or 'sell' decision.

Keywords

OLAPLEX, OLPX, SEC Form 4, Restricted Stock Units, RSU, Equity Incentive Plan, Director Compensation, Beneficial Ownership, Advent International